NCT03542981

Brief Summary

Interferential current is widely used as a popular treatment in painful musculoskeletal disorders. And total knee arthroplasty patients present with extreme pain immediately after surgery. So this study is aimed to investigate the effectiveness of interferential current implementation following total knee arthroplasty surgery. In this study interferential current compared with sham interferential current . Patients were assessed with pain, range of motion , edema and the amount of used paracetamol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
113

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2014

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

May 7, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

June 1, 2018

Completed
Last Updated

June 1, 2018

Status Verified

May 1, 2018

Enrollment Period

12 months

First QC Date

May 7, 2018

Last Update Submit

May 30, 2018

Conditions

Keywords

painsurgeryinterferential currenttotal knee arthroplasty

Outcome Measures

Primary Outcomes (1)

  • Change in Pain from baseline measured by visual analog scale

    Pain intensity that was measured by visual analog scale (minimum score:0; maximum score:100)(higher values represent worse outcome)

    Change in pain measured 5th and 30th days after surgery

Secondary Outcomes (3)

  • Change of Range of Motion from baseline

    Change of Range of Motion measured 5th and 30th days after surgery

  • Change of Edema from baseline

    Change of Edema measured 5th and 30th days after surgery

  • Amount of used paracetamol

    5th and 30th days after surgery

Study Arms (2)

Interferential Current Treatment

ACTIVE COMPARATOR

Interferential Current group received interferential current treatment 30 minutes, 2 times a day for 5 days after the surgery.

Device: Interferential Current

Sham Interferential Current Treatment

SHAM COMPARATOR

In the sham interferential Current treatment, no electrical stimulation was applied to the probes with the same pads for the same time.

Device: Sham Interferential Current

Interventions

Interferential Current Treatment
Sham Interferential Current Treatment

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who underwent total knee arthroplasty surgery

You may not qualify if:

  • Patients who had experienced of any electrotherapy prior to the TKA to be sure blinding of therapy
  • Patients who had history of any contraindication for electrotherapy
  • Patients who had chronic pain rather than knee OA
  • Patients who had experienced a known or suspected joint infection or a specific condition (ie, peripheral or central nervous system lesions, neoplasm, diabetes mellitus, osteonecrosis, recent trauma and pacemaker)
  • Patients who had history of stroke, central nervous disease, mental impairment or poor general health status that would interfere with functional assessments during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University School of Medicine Hospital

Izmir, Bornova, 35030, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Interventions

Electric Stimulation Therapy

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • mehmet r kadı, MD

    Ege University School of Medicine

    PRINCIPAL INVESTIGATOR
  • Simin Hepguler, prof

    Ege University School of Medicine

    STUDY DIRECTOR
  • Funda C Atamaz, prof

    Ege University School of Medicine

    STUDY CHAIR
  • Emine Dede, md

    Ege University School of Medicine

    STUDY CHAIR
  • Semih Aydogu, prof

    Ege University School of Medicine

    STUDY CHAIR
  • Kemal Aktuğlu, prof

    Ege University School of Medicine

    STUDY CHAIR
  • Nadir Ozkayın, prof

    Ege University School of Medicine

    STUDY CHAIR
  • Cihat Ozturk, prof

    Ege University School of Medicine

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 7, 2018

First Posted

June 1, 2018

Study Start

September 9, 2014

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

June 1, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations